Literature DB >> 9289857

[The demonstration of the radiation-induced production of tumor necrosis factor-alpha in Ewing's sarcoma RM 82 in vitro and in vivo].

C Rübe1, C Finke, F van Valen, K L Schäfer, B Dockhorn-Dworniczak, N Willich.   

Abstract

AIM: The expression of cytokines plays an important role in the transmission of the effects of ionizing radiation to tumor cells and normal tissue. Tumor necrosis factor alpha (TNF alpha), a pleiotropic monokine, is of special interest because of its cytotoxic effect on tumor cells and the induction of hemorrhagic necrosis in tumors. We examined the influence of ionizing radiation on TNF alpha production in a human Ewing's sarcoma cell line in vitro and in vivo.
METHODS: The protein and mRNA levels of the Ewing's sarcoma cell line RM 82 were examined in vitro with "Enhanced Amplified Sensitivity Immunoassay" (EASIA) and semiquantitative RT-PCR before and after treatment with single doses of 2 to 40 Gy, 1 to 72 hours after irradiation. After successful transplantation to nude mice, the time and dose correlation of TNF alpha mRNA production was examined in vivo.
RESULTS: In vitro, RM 82 had a basal protein level of TNF alpha of 20.1 +/- 4.3 pg/ml/10(6) cells. We observed a time- and dose-dependent increase of TNF alpha expression with a maximum of 125 pg/ml/10(6) (5.9 fold) 24 hours after irradiation with 20 Gy. At the mRNA level, the maximal up-regulation occurred 6 to 12 hours after 10 Gy. In vivo, the xenograft tumor maintained the capacity of TNF alpha expression. Time- and dose-dependency in mRNA production showed a maximum increase 6 hours after treatment with 10 Gy.
CONCLUSIONS: The presented experiments show in vitro a dose- and time-dependent up-regulation of TNF alpha in the Ewing's sarcoma cell line RM 82 on protein and mRNA level. For the first time this phenomenon was also observed in vivo in a human xenograft tumor. This tumor model could be used for further experiments to examine the role of TNF alpha as a biologic radiation response modifier in human tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9289857     DOI: 10.1007/bf03038316

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  40 in total

1.  Cellular and molecular aspects of human tumor radioresistance.

Authors:  R R Weichselbaum
Journal:  Important Adv Oncol       Date:  1991

2.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors:  S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

3.  Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors.

Authors:  I Nishiguchi; V Willingham; L Milas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-03       Impact factor: 7.038

4.  Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines.

Authors:  L Fransen; J Van der Heyden; R Ruysschaert; W Fiers
Journal:  Eur J Cancer Clin Oncol       Date:  1986-04

Review 5.  Cytotoxic mechanism of tumor necrosis factor-alpha.

Authors:  J W Larrick; S C Wright
Journal:  FASEB J       Date:  1990-11       Impact factor: 5.191

Review 6.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors:  K J Tracey; A Cerami
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

7.  Phase II study of recombinant human tumor necrosis factor in colorectal carcinoma.

Authors:  M Schaadt; M Pfreundschuh; G Lorscheidt; K M Peters; T Steinmetz; V Diehl
Journal:  J Biol Response Mod       Date:  1990-04

8.  Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.

Authors:  S Wu; C M Boyer; R S Whitaker; A Berchuck; J R Wiener; J B Weinberg; R C Bast
Journal:  Cancer Res       Date:  1993-04-15       Impact factor: 12.701

Review 9.  Molecular targets to overcome radioresistance.

Authors:  R R Weichselbaum; M A Beckett; D E Hallahan; D W Kufe; E E Vokes
Journal:  Semin Oncol       Date:  1992-08       Impact factor: 4.929

10.  Tumor necrosis factor-alpha augments radiation effects against human colon tumor xenografts.

Authors:  D S Gridley; S N Hammond; B H Liwnicz
Journal:  Anticancer Res       Date:  1994 May-Jun       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.